3K/DOQI clinical practice guidelines for chronic kidney disease:evaluation,classification and stratification Kidney Disease Outcome Quality Initiative[J]. Am J Kidney Dis,2002,39( 1 ) :1 -246.
4Guidelines Committee. 2003 European Society of Hypertensions: European Society of Cardiology guidelines for the management of arterial hypertension [ J ]. J hypertens,2003,21 (6) : 1011 - 1053.
5Iwao Ohno, Tatsuo Hosoya, Hideho Gomi, et al. Serum uric acid and renal prognosis in patients with IgA nephropathy [J]. Nephron,2001,87 (4) :333 - 339.
6Del Prete D, Gambaro G, Lupo A, et al. Precocious activation of genes of the rennin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis [ J ]. Kidney lnt, 2003,64 ( 1 ): 149 - 159.
7Jie Wu,Xiangmei Chen, Yuansheng Xie, et al. Characteristics and risk factors of intrarenal arterial lesions in patients with IgA ne- phropathy [ J ]. Nephrol Dial Transplant, 2005,20 (4) :719 - 727.
8叶任高.内科学[M].北京：人民卫生出版社,2001.294-307.
9沈庆法.中医临床肾脏病学[M].上海:上海科学技术文献出版社,1998:154.
10Klag MJ,Whelton PK,Randall BL,et al.End-stage renal disease in African-American and White man:16-year MRFIT findings[J].JAm Med Assos,1997,277:1293-1298
